Valérie Gordenne
Chief Scientific Officer
Reproductive Medicine
Mithra
Austria
Biography
Ms Gordenne has over 18 years of experience in the pharma industry with strong focus on R&D, (non)clinical trials, regulatory affairs and manufacturing. She holds a Master Degree in Pharmaceutical Sciences (Industrial Pharmacist) from the University of Liège. She started her career in Research and Development for a medium size pharmaceutical company called SMB Technology as Project Manager, and later become Qualified Person for a manufacturing site dedicated to investigational medicinal products. In 2004 she joined Mithra as Qualified Person where responsibilities also included Regulatory Affairs for pre- and post-marketing portfolio. Between 2008 and 2012 she acted as General Manager of Odyssea Pharma SA, the site dedicated to hormonal intra-uterine system Levosert© which is now a subsidiary of Actavis (NYSE: ACT). Following the acquisition of Uteron Pharma by Watson/Actavis (NYSE: ACT), she returned to Mithra as Chief Scientific Officer. Responsibilities at Mithra include R&D for the Company’s portfolio from discovery to marketing authorization.
Research Interest
Reproductive Medicine, Women Health
